These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19699770)

  • 1. Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel.
    Liu C; Zhao G; Liu J; Ma N; Chivukula P; Perelman L; Okada K; Chen Z; Gough D; Yu L
    J Control Release; 2009 Dec; 140(3):277-83. PubMed ID: 19699770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
    Zhu C; Jung S; Luo S; Meng F; Zhu X; Park TG; Zhong Z
    Biomaterials; 2010 Mar; 31(8):2408-16. PubMed ID: 19963269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
    Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
    J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.
    Swaminathan SK; Roger E; Toti U; Niu L; Ohlfest JR; Panyam J
    J Control Release; 2013 Nov; 171(3):280-7. PubMed ID: 23871962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
    Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
    J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression.
    Jang YL; Yun UJ; Lee MS; Kim MG; Son S; Lee K; Chae SY; Lim DW; Kim HT; Kim SH; Jeong JH
    Int J Pharm; 2012 Sep; 434(1-2):488-93. PubMed ID: 22613208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers.
    Aliabadi HM; Landry B; Bahadur RK; Neamnark A; Suwantong O; Uludağ H
    Macromol Biosci; 2011 May; 11(5):662-72. PubMed ID: 21322108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
    Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
    Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells.
    Sardo C; Bassi B; Craparo EF; Scialabba C; Cabrini E; Dacarro G; D'Agostino A; Taglietti A; Giammona G; Pallavicini P; Cavallaro G
    Int J Pharm; 2017 Mar; 519(1-2):113-124. PubMed ID: 28093325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.
    Yang X; Iyer AK; Singh A; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Sci Rep; 2015 Feb; 5():8509. PubMed ID: 25687880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
    Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoresistance of CD133(+) colon cancer may be related with increased survivin expression.
    Lee MR; Ji SY; Mia-Jan K; Cho MY
    Biochem Biophys Res Commun; 2015 Jul; 463(3):229-34. PubMed ID: 26002465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
    Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
    Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.